Raltegravir and Cachexia - a phase IV clinical study of FDA data

Summary:

Cachexia is reported as a side effect among people who take Raltegravir (raltegravir), especially for people who are male, 20-29 old, have been taking the drug for 1 - 6 months also take Emtricitabine, and have Hiv infection.

The phase IV clinical study analyzes which people have Cachexia when taking Raltegravir. It is created by eHealthMe based on reports of 5,050 people who have side effects when taking Raltegravir from the FDA, and is updated regularly.

What is Raltegravir?

Raltegravir has active ingredients of raltegravir. eHealthMe is studying from 5,054 Raltegravir users. Check the latest studies of Raltegravir.

What is Cachexia?

Cachexia (loss of weight) is found to be associated with 657 drugs and 1,207 conditions by eHealthMe. Check the latest studies of Cachexia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

5,050 people reported to have side effects when taking Raltegravir.
Among them, 19 people (0.38%) have Cachexia.

Among these 19 people:

How long have people been on Raltegravir when they have Cachexia? *

What is the gender of people who have Cachexia when taking Raltegravir? *

female: 43.75 %
male: 56.25 %

What is the age of people who have Cachexia when taking Raltegravir? *

What are other drugs people take besides Raltegravir? *

What are other side effects people have besides Cachexia? *

Oral Candidiasis (fungal infection of mouth): 10 people, 52.63%
Death: 8 people, 42.11%
Herpes Virus Infection: 7 people, 36.84%
Oesophageal Candidiasis (fungal infection of oesophagus): 7 people, 36.84%
Haemorrhage (bleeding): 7 people, 36.84%
Diarrhea: 4 people, 21.05%
Fatigue (feeling of tiredness): 4 people, 21.05%
Fever: 4 people, 21.05%
Anaemia (lack of blood): 3 people, 15.79%
Drug Resistance (reduction in effectiveness of a drug): 3 people, 15.79%

What are the existing conditions these people have? *

Hiv Infection: 11 people, 57.89%
Pulmonary Tuberculosis (lungs tuberculosis): 7 people, 36.84%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 5.26%
Reactive Psychosis (extreme stress): 1 person, 5.26%
Nausea And Vomiting: 1 person, 5.26%
Hepatitis B: 1 person, 5.26%
Dehydration (dryness resulting from the removal of water): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Raltegravir and have Cachexia?

- Check whether Cachexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Raltegravir:

Raltegravir (5,054 reports)

Cachexia treatments and more:

Cachexia (7,763 reports)

Browse all side effects of Raltegravir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cachexia:

Cachexia (657 drugs)

Browse all the conditions that are associated with Cachexia:

Cachexia (1,207 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raltegravir (the active ingredients of Raltegravir) and Raltegravir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.